These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 39304237

  • 1. Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial.
    Afolabi BB, Babah OA, Adeyemo TA, Balogun M, Banke-Thomas A, Abioye AI, Akinajo OR, Galadanci HS, Quao RA, Adelabu H, Sam-Agudu NA, Adaramoye VO, Abubakar A, Banigbe B, Olorunfemi G, Beňová L, Larsson EC, Annerstedt KS, Hanson C, Thornton J, IVON Trial Investigators.
    Lancet Glob Health; 2024 Oct; 12(10):e1649-e1659. PubMed ID: 39304237
    [Abstract] [Full Text] [Related]

  • 2. Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate to severe postpartum anaemia in Nigerian women (IVON-PP): protocol for an open-label randomised controlled type 1 hybrid effectiveness-implementation trial.
    Afolabi BB, Adaramoye VO, Adeyemo TA, Balogun M, Mitchell EJ, Walker K, Akinajo OR, Abioye IA, Banke-Thomas A, Babah OA, Chieme CF, Oshodi Y, Quao R, Eboreime EA, Ogunsola F.
    BMJ Open; 2024 Aug 17; 14(8):e086553. PubMed ID: 39153791
    [Abstract] [Full Text] [Related]

  • 3. Intravenous versus oral iron for iron deficiency anaemia in pregnant Nigerian women (IVON): study protocol for a randomised hybrid effectiveness-implementation trial.
    Afolabi BB, Babah OA, Akinajo OR, Adaramoye VO, Adeyemo TA, Balogun M, Banke-Thomas A, Quao RA, Olorunfemi G, Abioye AI, Galadanci HS, Sam-Agudu NA.
    Trials; 2022 Sep 08; 23(1):763. PubMed ID: 36076211
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial.
    Vanobberghen F, Lweno O, Kuemmerle A, Mwebi KD, Asilia P, Issa A, Simon B, Mswata S, Schmidlin S, Glass TR, Abdulla S, Daubenberger C, Tanner M, Meyer-Monard S.
    Lancet Glob Health; 2021 Feb 08; 9(2):e189-e198. PubMed ID: 33245866
    [Abstract] [Full Text] [Related]

  • 5. Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
    Pasricha SR, Mwangi MN, Moya E, Ataide R, Mzembe G, Harding R, Zinenani T, Larson LM, Demir AY, Nkhono W, Chinkhumba J, Simpson JA, Clucas D, Stones W, Braat S, Phiri KS.
    Lancet; 2023 May 13; 401(10388):1595-1609. PubMed ID: 37088092
    [Abstract] [Full Text] [Related]

  • 6. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
    Khalafallah AA, Hyppa A, Chuang A, Hanna F, Wilson E, Kwok C, Yan C, Gray Z, Mathew R, Falloon P, Dennis A, Pavlov T, Allen JC.
    Semin Hematol; 2018 Oct 13; 55(4):223-234. PubMed ID: 30502851
    [Abstract] [Full Text] [Related]

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 8. Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial.
    Neogi SB, Devasenapathy N, Singh R, Bhushan H, Shah D, Divakar H, Zodpey S, Malik S, Nanda S, Mittal P, Batra A, Chauhan MB, Yadav S, Dongre H, Saluja S, Malhotra V, Gupta A, Sangwan R, Radhika AG, Singh A, Bhaskaran S, Kotru M, Sikka M, Agarwal S, Francis P, Mwinga K, Baswal D.
    Lancet Glob Health; 2019 Dec 01; 7(12):e1706-e1716. PubMed ID: 31708151
    [Abstract] [Full Text] [Related]

  • 9. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
    Lyseng-Williamson KA, Keating GM.
    Drugs; 2009 Dec 01; 69(6):739-56. PubMed ID: 19405553
    [Abstract] [Full Text] [Related]

  • 10. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial.
    Khalafallah AA, Yan C, Al-Badri R, Robinson E, Kirkby BE, Ingram E, Gray Z, Khelgi V, Robertson IK, Kirkby BP.
    Lancet Haematol; 2016 Sep 01; 3(9):e415-25. PubMed ID: 27570088
    [Abstract] [Full Text] [Related]

  • 11. Interventions for treating iron deficiency anaemia in inflammatory bowel disease.
    Gordon M, Sinopoulou V, Iheozor-Ejiofor Z, Iqbal T, Allen P, Hoque S, Engineer J, Akobeng AK.
    Cochrane Database Syst Rev; 2021 Jan 20; 1(1):CD013529. PubMed ID: 33471939
    [Abstract] [Full Text] [Related]

  • 12. Role of Intravenous Ferric Carboxy-maltose in Pregnant Women with Iron Deficiency Anaemia.
    Mishra V, Gandhi K, Roy P, Hokabaj S, Shah KN.
    J Nepal Health Res Counc; 2017 Sep 08; 15(2):96-99. PubMed ID: 29016575
    [Abstract] [Full Text] [Related]

  • 13. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
    Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J, FER-ASAP investigators.
    J Perinat Med; 2017 May 24; 45(4):443-453. PubMed ID: 27278921
    [Abstract] [Full Text] [Related]

  • 14. Intravenous ferric carboxymaltose for anaemia in pregnancy.
    Froessler B, Collingwood J, Hodyl NA, Dekker G.
    BMC Pregnancy Childbirth; 2014 Mar 25; 14():115. PubMed ID: 24667031
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women.
    Shim JY, Kim MY, Kim YJ, Lee Y, Lee JJ, Jun JK, Shin JC, Cho YK, Lee KY, Kim A, Song TB.
    BMC Pregnancy Childbirth; 2018 Aug 28; 18(1):349. PubMed ID: 30153811
    [Abstract] [Full Text] [Related]

  • 16. Protocol for a multicentre, parallel-group, open-label randomised controlled trial comparing ferric carboxymaltose with the standard of care in anaemic Malawian pregnant women: the REVAMP trial.
    Mwangi MN, Mzembe G, Moya E, Braat S, Harding R, Robberstad B, Simpson J, Stones W, Rogerson S, Biselele K, Chinkhumba J, Larson L, Ataíde R, Phiri KS, Pasricha SR.
    BMJ Open; 2021 Nov 23; 11(11):e053288. PubMed ID: 34815287
    [Abstract] [Full Text] [Related]

  • 17. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty.
    Bisbe E, Moltó L, Arroyo R, Muniesa JM, Tejero M.
    Br J Anaesth; 2014 Sep 23; 113(3):402-9. PubMed ID: 24780615
    [Abstract] [Full Text] [Related]

  • 18. Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis.
    Rogozińska E, Daru J, Nicolaides M, Amezcua-Prieto C, Robinson S, Wang R, Godolphin PJ, Saborido CM, Zamora J, Khan KS, Thangaratinam S.
    Lancet Haematol; 2021 Jul 23; 8(7):e503-e512. PubMed ID: 34171281
    [Abstract] [Full Text] [Related]

  • 19. Acceptability of IV iron treatment for iron deficiency anaemia in pregnancy in Nigeria: a qualitative study with pregnant women, domestic decision-makers, and health care providers.
    Akinajo OR, Babah OA, Banke-Thomas A, Beňová L, Sam-Agudu NA, Balogun MR, Adaramoye VO, Galadanci HS, Quao RA, Afolabi BB, Annerstedt KS.
    Reprod Health; 2024 Feb 13; 21(1):22. PubMed ID: 38347614
    [Abstract] [Full Text] [Related]

  • 20. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
    Ponikowski P, Kirwan BA, Anker SD, McDonagh T, Dorobantu M, Drozdz J, Fabien V, Filippatos G, Göhring UM, Keren A, Khintibidze I, Kragten H, Martinez FA, Metra M, Milicic D, Nicolau JC, Ohlsson M, Parkhomenko A, Pascual-Figal DA, Ruschitzka F, Sim D, Skouri H, van der Meer P, Lewis BS, Comin-Colet J, von Haehling S, Cohen-Solal A, Danchin N, Doehner W, Dargie HJ, Motro M, Butler J, Friede T, Jensen KH, Pocock S, Jankowska EA, AFFIRM-AHF investigators.
    Lancet; 2020 Dec 12; 396(10266):1895-1904. PubMed ID: 33197395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.